OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy
- PMID: 17093286
- DOI: 10.1200/JCO.2006.07.5630
OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy
Comment on
-
OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.J Clin Oncol. 2006 Jan 20;24(3):394-400. doi: 10.1200/JCO.2005.03.0106. J Clin Oncol. 2006. PMID: 16421419 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
